Kenzie Shippy
Physician Assistant · Denver, CONPI 1649823113
Payments from drug & device makers
Across 119 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$363
- Pfizer$304
- AbbVie$279
- Lilly USA, LLC$249
- Novo Nordisk$236
- AstraZeneca$197
- plus $777 from 21 others
What the payments were for
- Food & beverage$2,393100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 13 | $363 |
| Pfizer | 15 | $304 |
| AbbVie | 12 | $279 |
| Lilly USA, LLC | 15 | $249 |
| Novo Nordisk | 13 | $236 |
| AstraZeneca | 12 | $197 |
| GSK | 6 | $126 |
| Merck | 5 | $86 |
| Boehringer Ingelheim | 3 | $65 |
| Exact Sciences | 3 | $55 |
| Bayer | 2 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| Grifols USA, LLC | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Exeltis, USA Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Alkermes, Inc. | 1 | $17 |
| Viiv Healthcare Company | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Medicure Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$122
How this compares
$2,404 in reported general payments places this provider in the 85th percentile of 2,849 physician assistant providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 76 | $104,534 |
| EliquisApixaban | 45 | $57,492 |
| MounjaroTirzepatide | 43 | $47,351 |
| XareltoRivaroxaban | 38 | $41,819 |
| JanuviaSitagliptin Phosphate | 25 | $35,861 |
| TrulicityDulaglutide | 28 | $35,081 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $29,476 |
| JardianceEmpagliflozin | 14 | $24,876 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $13,273 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 14 | $8,550 |
| BelsomraSuvorexant | 12 | $5,463 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 14 | $4,450 |
| Gabapentin | 129 | $2,746 |
| Atorvastatin Calcium | 321 | $2,529 |
| Levothyroxine Sodium | 245 | $2,461 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $236 | $104,53476 claims |
| Lilly USA, LLCMounjaro, Trulicity | $249 | $82,43271 claims |
| PfizerEliquis | $304 | $57,49245 claims |
| MerckJanuvia, Belsomra | $86 | $41,32437 claims |
| GSKTrelegy Ellipta, Arexvy | $126 | $33,92551 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $65 | $33,42628 claims |
| AstraZenecaBreztri Aerosphere | $197 | $13,27313 claims |
| AbbVieSynthroid | $279 | $2,22537 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Denver
- Kristen LervikDenver$131K
- Emily FrischDenver$79K
- Andrew GardnerDenver$68K
- Ethan MytingerDenver$19K
- Karen WilderDenver$16K
- Mariam MikeladzeDenver$12K
- Laura MurrayDenver$10K
- Corbin RogersDenver$10K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.